Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 37.45 M33.33 M— — Research & development 10.73 M13.71 M— — Operating income 3.72 M7.53 M-2.63 M — Non-Operating Income, Total 27.96 M852 K— — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses -708 K-287 K— — Unusual income/expense 28.67 M1.14 M— — Pretax income 24.24 M8.38 M-2.63 M — Equity in earnings ——— — Taxes 2 M1.9 M— — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 26.23 M6.44 M-47.35 M — Discontinued operations ——— — Net income 26.23 M6.44 M-47.35 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 26.23 M6.44 M-47.35 M — Basic earnings per share (Basic EPS) -0.650.09— — Diluted earnings per share (Diluted EPS) -0.650.08-0.93 — Average basic shares outstanding 40.12 M73.69 M50.9 M — Diluted shares outstanding 40.12 M80.74 M50.9 M — EBITDA 4.42 M8.23 M— — EBIT 3.72 M7.53 M— — Cost of revenue 15.9 M14.79 M— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 700 K700 K2.63 M —